NA
ALT icon

NewEdge Advisors’s Altimmune ALT Stock Holding History

NewEdge Advisors’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.74K Hold
1,888
– – ﹤0.01% 3686
2026
Q1 		$5.82K Hold
1,888
– – ﹤0.01% 3542
2025
Q4 		$6.82K Sell
1,888
-1,300
-41% -$5.67K ﹤0.01% 3585
2025
Q3 		$12K Sell
3,188
-300
-9% -$1.16K ﹤0.01% 3277
2025
Q2 		$13.5K Sell
3,488
-21,271
-86% -$115K ﹤0.01% 3095
2025
Q1 		$124K Sell
24,759
-366
-1% -$2.32K ﹤0.01% 2228
2024
Q4 		$181K Buy
25,125
+579
+2% +$4.42K ﹤0.01% 2110
2024
Q3 		$151K Buy
24,546
+1,614
+7% +$10.9K ﹤0.01% 2067
2024
Q2 		$152K Sell
22,932
-18,518
-45% -$137K ﹤0.01% 1990
2024
Q1 		$422K Buy
41,450
+31,450
+315% +$320K ﹤0.01% 1442
2023
Q4 		$113K Buy
+10,000
New +$41.8K ﹤0.01% 1904

Other funds holding ALT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NewEdge Advisors's ALT Position: Q2 2026 in Review

NewEdge Advisors held its Altimmune (ALT) position steady in Q2 2026 at 1,888 shares worth $5.74K. The position accounts for ﹤0.01% of the portfolio, ranked #3686.

NewEdge Advisors first reported a position in ALT in Q4 2023 and has held it in 11 quarters since. The position peaked at $422K in Q1 2024. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • NewEdge Advisors held 1,888 shares of Altimmune worth $5.74K as of Q2 2026.
  • NewEdge Advisors left its Altimmune share count unchanged in Q2 2026.
  • Altimmune made up ﹤0.01% of NewEdge Advisors's portfolio in Q2 2026, its #3686 holding.
  • NewEdge Advisors first reported a position in Altimmune in Q4 2023 and has held it in 11 quarters since.
  • NewEdge Advisors's Altimmune position peaked at $422K in Q1 2024.
  • 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on NewEdge Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.